231 related articles for article (PubMed ID: 28191816)
1. Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer Activity.
Koya T; Yanagisawa R; Higuchi Y; Sano K; Shimodaira S
Sci Rep; 2017 Feb; 7():42145. PubMed ID: 28191816
[TBL] [Abstract][Full Text] [Related]
2. Interferon alpha induces generation of semi-mature dendritic cells with high pro-inflammatory and cytotoxic potential.
Leplina OY; Tyrinova TV; Tikhonova MA; Ostanin AA; Chernykh ER
Cytokine; 2015 Jan; 71(1):1-7. PubMed ID: 25174880
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells.
Paquette RL; Hsu NC; Kiertscher SM; Park AN; Tran L; Roth MD; Glaspy JA
J Leukoc Biol; 1998 Sep; 64(3):358-67. PubMed ID: 9738663
[TBL] [Abstract][Full Text] [Related]
4. Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.
Naito K; Ueda Y; Itoh T; Fuji N; Shimizu K; Yano Y; Yamamoto Y; Imura K; Kohara J; Iwamoto A; Shiozaki A; Tamai H; Shimizu T; Mazda O; Yamagishi H
Int J Oncol; 2006 Jun; 28(6):1481-9. PubMed ID: 16685449
[TBL] [Abstract][Full Text] [Related]
5. Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-alpha.
Della Bella S; Nicola S; Riva A; Biasin M; Clerici M; Villa ML
J Leukoc Biol; 2004 Jan; 75(1):106-16. PubMed ID: 14525963
[TBL] [Abstract][Full Text] [Related]
6. Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells.
Radvanyi LG; Banerjee A; Weir M; Messner H
Scand J Immunol; 1999 Nov; 50(5):499-509. PubMed ID: 10564553
[TBL] [Abstract][Full Text] [Related]
7. Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis.
Korthals M; Safaian N; Kronenwett R; Maihöfer D; Schott M; Papewalis C; Diaz Blanco E; Winter M; Czibere A; Haas R; Kobbe G; Fenk R
J Transl Med; 2007 Sep; 5():46. PubMed ID: 17894866
[TBL] [Abstract][Full Text] [Related]
8. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia].
Wu CY; Zhang LS; Zhang YF; Chai Y; Yi LC; Song FX
Ai Zheng; 2005 Apr; 24(4):425-31. PubMed ID: 15820064
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.
Anguille S; Lion E; Tel J; de Vries IJ; Couderé K; Fromm PD; Van Tendeloo VF; Smits EL; Berneman ZN
PLoS One; 2012; 7(12):e51851. PubMed ID: 23284789
[TBL] [Abstract][Full Text] [Related]
10. Generation of mature dendritic cells fully capable of T helper type 1 polarization using OK-432 combined with prostaglandin E(2).
Sato M; Takayama T; Tanaka H; Konishi J; Suzuki T; Kaiga T; Tahara H
Cancer Sci; 2003 Dec; 94(12):1091-8. PubMed ID: 14662025
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo.
Paquette RL; Hsu N; Said J; Mohammed M; Rao NP; Shih G; Schiller G; Sawyers C; Glaspy JA
Leukemia; 2002 Aug; 16(8):1484-9. PubMed ID: 12145689
[TBL] [Abstract][Full Text] [Related]
12. Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.
Nieda M; Terunuma H; Eiraku Y; Deng X; Nicol AJ
Exp Dermatol; 2015 Jan; 24(1):35-41. PubMed ID: 25363560
[TBL] [Abstract][Full Text] [Related]
13. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
[TBL] [Abstract][Full Text] [Related]
14. OK-432 synergizes with IFN-γ to confer dendritic cells with enhanced antitumor immunity.
Pan K; Lv L; Zheng HX; Zhao JJ; Pan QZ; Li JJ; Weng DS; Wang DD; Jiang SS; Chang AE; Li Q; Xia JC
Immunol Cell Biol; 2014 Mar; 92(3):263-74. PubMed ID: 24296809
[TBL] [Abstract][Full Text] [Related]
15. Induction of suppressive phenotype in monocyte-derived dendritic cells by leukemic cell products and IL-1β.
Motta JM; Sperandio A; Castelo-Branco MT; Rumjanek VM
Hum Immunol; 2014 Jul; 75(7):641-9. PubMed ID: 24768898
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid and chondroitin sulphate A rapidly promote differentiation of immature DC with upregulation of costimulatory and antigen-presenting molecules, and enhancement of NF-kappaB and protein kinase activity.
Yang R; Yan Z; Chen F; Hansson GK; Kiessling R
Scand J Immunol; 2002 Jan; 55(1):2-13. PubMed ID: 11841687
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of dendritic cells matured early with OK-432 (Picibanil), prostaglandin E2, and interferon-alpha as a vaccine for a hormone refractory prostate cancer cell line.
Yoo C; Do HA; Jeong IG; Park H; Hwang JJ; Hong JH; Cho JS; Choo MS; Ahn H; Kim CS
J Korean Med Sci; 2010 Sep; 25(9):1284-90. PubMed ID: 20808670
[TBL] [Abstract][Full Text] [Related]
18. IFN-alpha skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo.
Papewalis C; Jacobs B; Wuttke M; Ullrich E; Baehring T; Fenk R; Willenberg HS; Schinner S; Cohnen M; Seissler J; Zacharowski K; Scherbaum WA; Schott M
J Immunol; 2008 Feb; 180(3):1462-70. PubMed ID: 18209041
[TBL] [Abstract][Full Text] [Related]
19. [Study on induction of dendritic cells from myeloid leukemia cell lines and their antitumor immune function].
Luo YP; Li YG; Cai DC; Ren H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):229-35. PubMed ID: 12513792
[TBL] [Abstract][Full Text] [Related]
20. The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells.
Liu S; Yu Y; Zhang M; Wang W; Cao X
J Immunol; 2001 May; 166(9):5407-15. PubMed ID: 11313377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
